Se Hoon Park Selected Research

Disease Progression

3/2024	Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
9/2023	Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance.
4/2023	Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy.
1/2023	Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma.
1/2021	Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).
1/2020	Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
1/2020	First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.
1/2020	Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study.
1/2020	Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.
1/2019	Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Se Hoon Park Research Topics

Disease

143	Neoplasms (Cancer) 03/2024 - 09/2004
94	Stomach Neoplasms (Stomach Cancer) 01/2023 - 10/2004
43	Carcinoma (Carcinomatosis) 03/2024 - 01/2009
27	Disease Progression 03/2024 - 10/2004
23	Adenocarcinoma 01/2023 - 01/2004
23	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2002
22	Neoplasm Metastasis (Metastasis) 01/2024 - 03/2008
20	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 01/2010
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 11/2003
11	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 11/2014
10	Neutropenia 12/2023 - 11/2004
10	Anemia 01/2023 - 09/2004
9	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 05/2012
8	Microsatellite Instability 01/2020 - 09/2010
8	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 05/2009
7	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2015
7	Fatigue 01/2022 - 04/2015
7	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 02/2012
7	Hepatocellular Carcinoma (Hepatoma) 08/2012 - 11/2004
6	Pneumonia (Pneumonitis) 12/2023 - 04/2015
6	Ascites 11/2023 - 01/2011
6	Colonic Neoplasms (Colon Cancer) 01/2020 - 09/2010
5	Pain (Aches) 02/2024 - 03/2008
5	Diarrhea 01/2022 - 01/2004
5	Esophageal Squamous Cell Carcinoma 07/2017 - 01/2012
4	Pruritus (Itching) 01/2024 - 10/2019
4	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 04/2015
4	Hypertension (High Blood Pressure) 01/2023 - 08/2016
4	Fever (Fevers) 12/2021 - 12/2005
4	Carcinogenesis 10/2018 - 08/2009
3	Thrombocytopenia (Thrombopenia) 12/2023 - 11/2004
3	Sepsis (Septicemia) 12/2023 - 01/2004
3	Febrile Neutropenia 12/2023 - 02/2012
3	Rectal Neoplasms (Rectal Cancer) 01/2023 - 02/2008
3	Nausea 01/2022 - 05/2012

Drug/Important Bio-Agent (IBA)

41	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 11/2003
31	PlatinumIBA 03/2024 - 01/2009
27	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 08/2002
23	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2004
21	Docetaxel (Taxotere)FDA Link 12/2021 - 10/2004
21	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2004
20	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2009
18	Gemcitabine FDA Link 03/2024 - 01/2005
18	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2005
14	Immune Checkpoint InhibitorsIBA 02/2023 - 09/2019
13	pembrolizumabIBA 04/2024 - 01/2018
13	Proteins (Proteins, Gene)FDA Link 02/2021 - 09/2010
12	B7-H1 AntigenIBA 11/2023 - 01/2016
12	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2004
12	Leucovorin (Folinic Acid)FDA Link 01/2021 - 09/2005
11	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2009
9	pazopanib FDA Link 04/2018 - 01/2014
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2015 - 06/2008
7	avelumabIBA 09/2023 - 01/2020
7	Simvastatin (Zocor)FDA LinkGeneric 01/2023 - 09/2009
7	Sunitinib (Sutent)FDA Link 01/2023 - 01/2010
7	Everolimus FDA Link 01/2018 - 07/2011
6	atezolizumabIBA 12/2023 - 10/2019
6	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2023 - 01/2016
6	Trastuzumab (Herceptin)FDA Link 01/2023 - 03/2015
6	Cetuximab (Erbitux)FDA Link 01/2017 - 07/2013
6	Hemoglobins (Hemoglobin)IBA 02/2016 - 01/2006
5	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 01/2005
5	RamucirumabIBA 02/2024 - 01/2019
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2004
5	Phosphotransferases (Kinase)IBA 10/2021 - 06/2011
5	Monoclonal AntibodiesIBA 01/2020 - 09/2015
5	Gefitinib (Iressa)FDA Link 01/2020 - 07/2004
5	ParaffinIBA 01/2014 - 06/2010
4	erdafitinibIBA 11/2023 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2023 - 01/2017
4	RNA (Ribonucleic Acid)IBA 04/2020 - 02/2017
4	regorafenibIBA 01/2020 - 01/2017
4	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 11/2003
4	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 04/2012
4	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 01/2011
3	enfortumab vedotinIBA 03/2024 - 10/2022
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2023 - 10/2018
3	NivolumabIBA 04/2023 - 01/2021
3	olaparibIBA 01/2023 - 12/2017
3	human ERBB2 proteinIBA 01/2022 - 01/2019
3	LigandsIBA 04/2020 - 02/2017

Therapy/Procedure

122	Drug Therapy (Chemotherapy) 03/2024 - 01/2004
81	Therapeutics 04/2024 - 11/2003
21	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 08/2002
16	Chemoradiotherapy 02/2024 - 12/2003
12	Adjuvant Chemotherapy 01/2024 - 09/2010
12	Radiotherapy 12/2020 - 10/2004
10	Immunotherapy 01/2023 - 01/2017
9	Castration 01/2023 - 11/2014
6	Precision Medicine 02/2024 - 06/2011
6	Aftercare (After-Treatment) 11/2023 - 06/2007
6	Gastrectomy 01/2021 - 01/2010
6	Adjuvant Chemoradiotherapy 04/2020 - 12/2005
6	Salvage Therapy 10/2019 - 11/2008
5	Neoadjuvant Therapy 02/2024 - 05/2012
4	Nephrectomy 08/2023 - 12/2019
4	Metastasectomy 01/2021 - 09/2010
3	Nephroureterectomy 01/2024 - 07/2018
3	Cystectomy 07/2022 - 07/2018